How can immunology contribute to the control of tuberculosis? (Q34572120)

3 August 2017

1 reference

title

How can immunology contribute to the control of tuberculosis? (English)

1 reference

3 August 2017

0 references

0 references

Kaufmann SH

1

1 reference

3 August 2017

1 October 2001

1 reference

Nature Reviews Immunology

3 August 2017

1 reference

3 August 2017

1

1 reference

3 August 2017

1

1 reference

3 August 2017

20-30

1 reference

Is the development of a new tuberculosis vaccine possible?

3 August 2017

1 reference

7 January 2021

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

1 reference

7 January 2021

Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family

1 reference

7 January 2021

Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting

1 reference

7 January 2021

Confrontation between intracellular bacteria and the immune system.

1 reference

7 January 2021

Macrophage receptors for Mycobacterium tuberculosis

1 reference

7 January 2021

Interactions between Mycobacterium tuberculosis and host cells: are mycobacterial sugars the key?

1 reference

7 January 2021

Essential role for cholesterol in entry of mycobacteria into macrophages

1 reference

7 January 2021

Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival

1 reference

7 January 2021

Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors

1 reference

7 January 2021

A macrophage invasion mechanism of pathogenic mycobacteria

1 reference

7 January 2021

Induction of direct antimicrobial activity through mammalian toll-like receptors

1 reference

7 January 2021

An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets

1 reference

7 January 2021

A coat protein on phagosomes involved in the intracellular survival of mycobacteria

1 reference

7 January 2021

Iron and Mycobacterium tuberculosis infection

1 reference

7 January 2021

Iron metabolism: iron deficiency and iron overload

1 reference

7 January 2021

The many faces of host responses to tuberculosis

1 reference

7 January 2021

Identification of nitric oxide synthase as a protective locus against tuberculosis

1 reference

7 January 2021

Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB.

1 reference

7 January 2021

Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens

1 reference

7 January 2021

Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase

1 reference

7 January 2021

Anaerobic nitrate reductase (narGHJI) activity of Mycobacterium bovis BCG in vitro and its contribution to virulence in immunodeficient mice

1 reference

7 January 2021

gamma/delta and other unconventional T lymphocytes: what do they see and what do they do?

1 reference

7 January 2021

CD1 and CD1-restricted T cells in infections with intracellular bacteria

1 reference

7 January 2021

Immunology of tuberculosis

1 reference

7 January 2021

Toll-like receptors in the induction of the innate immune response

1 reference

7 January 2021

Disseminated tuberculosis in interferon gamma gene-disrupted mice

1 reference

7 January 2021

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

1 reference

7 January 2021

Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology

1 reference

7 January 2021

Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection.

1 reference

7 January 2021

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

1 reference

7 January 2021

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

7 January 2021

Mycobacterial infection of macrophages results in membrane-permeable phagosomes.

1 reference

7 January 2021

Trafficking and release of mycobacterial lipids from infected macrophages

1 reference

7 January 2021

Lipoprotein access to MHC class I presentation during infection of murine macrophages with live mycobacteria.

1 reference

7 January 2021

Intersection of group I CD1 molecules and mycobacteria in different intracellular compartments of dendritic cells.

1 reference

7 January 2021

Mycobacterial lysocardiolipin is exported from phagosomes upon cleavage of cardiolipin by a macrophage-derived lysosomal phospholipase A2.

1 reference

7 January 2021

Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells

1 reference

7 January 2021

Apoptosis of macrophages and T cells in tuberculosis associated caseous necrosis

1 reference

7 January 2021

Killing vs suicide in antibacterial defence.

1 reference

7 January 2021

An antimicrobial activity of cytolytic T cells mediated by granulysin

1 reference

7 January 2021

Differential effects of cytolytic T cell subsets on intracellular infection

1 reference

7 January 2021

ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors

1 reference

7 January 2021

Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection

1 reference

7 January 2021

MHC class Ia-restricted T cells partially account for beta2-microglobulin-dependent resistance to Mycobacterium tuberculosis.

1 reference

7 January 2021

Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis

1 reference

7 January 2021

Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice.

1 reference

7 January 2021

Immunization with f-Met peptides induces immune reactivity against Mycobacterium tuberculosis

1 reference

7 January 2021

Induction of M3-restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis

1 reference

7 January 2021

Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells.

1 reference

7 January 2021

Mycobacterium tuberculosis-reactive CD8+ T lymphocytes: the relative contribution of classical versus nonclassical HLA restriction

1 reference

7 January 2021

CD1-restricted T-cell responses and microbial infection

1 reference

7 January 2021

The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids

1 reference

7 January 2021

CD1c molecules broadly survey the endocytic system

1 reference

7 January 2021

Contribution of alpha/beta and gamma/delta T lymphocytes to immunity against Mycobacterium bovis bacillus Calmette Guérin: studies with T cell receptor-deficient mutant mice

1 reference

7 January 2021

Phenotypically Activated γδ T Lymphocytes in the Peripheral Blood of Patients with Tuberculosis

1 reference

7 January 2021

Vγ9 / Vδ2 T lymphocytes reduce the viability of intracellularMycobacterium tuberculosis

1 reference

7 January 2021

Tuberculosis vaccine development: recent progress

1 reference

7 January 2021

In vivo veritas: the search for TB drug targets goes live

1 reference

7 January 2021

Therapy of tuberculosis in mice by DNA vaccination.

1 reference

7 January 2021

How environmental mycobacteria may predetermine the protective efficacy of BCG

1 reference

7 January 2021

A nonhuman primate model for preclinical testing of new tuberculosis vaccines

1 reference

7 January 2021

The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease

1 reference

7 January 2021

Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization

1 reference

7 January 2021

Introduction: from genome to function – monitoring global responses in infectious diseases by interrogating the transcriptome and proteome

1 reference

7 January 2021

The meaning and impact of the human genome sequence for microbiology

1 reference

7 January 2021

Variation in protection by BCG: implications of and for heterologous immunity

1 reference

7 January 2021

Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

1 reference

7 January 2021

A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival

1 reference

7 January 2021

Prospects for better tuberculosis vaccines

1 reference

7 January 2021

Interpreting cell wall 'virulence factors' of Mycobacterium tuberculosis

1 reference

7 January 2021

Vaccination against tuberculosis by DNA injection

1 reference

7 January 2021

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

1 reference

7 January 2021

Immune response against heat shock proteins in infectious diseases.

1 reference

7 January 2021

Autoimmune intestinal pathology induced by hsp60-specific CD8 T cells.

1 reference

7 January 2021

Lack of protection in mice and necrotizing bronchointerstitial pneumonia with bronchiolitis in guinea pigs immunized with vaccines directed against the hsp60 molecule of Mycobacterium tuberculosis

1 reference

7 January 2021

From genomics to vaccines: malaria as a model system.

1 reference

7 January 2021

Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library

1 reference

7 January 2021

T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection

1 reference

7 January 2021

Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6.

1 reference

7 January 2021

Improving vaccine performance with adjuvants

1 reference

7 January 2021

Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes

1 reference

7 January 2021

Exploiting the immune system: toward new vaccines against intracellular bacteria

1 reference

7 January 2021

Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines

1 reference

7 January 2021

Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages

1 reference

7 January 2021

Boosting vaccine for tuberculosis

1 reference

7 January 2021

Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting

1 reference

7 January 2021

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

1 reference

7 January 2021

Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis

1 reference

7 January 2021

Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens.

1 reference

7 January 2021

Comparative genomics of BCG vaccines by whole-genome DNA microarray

1 reference

7 January 2021

Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis

1 reference

7 January 2021

ESAT-6 subunit vaccination against Mycobacterium tuberculosis

1 reference

7 January 2021

Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis

1 reference

7 January 2021

Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene

1 reference

7 January 2021

The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages

1 reference

7 January 2021

A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis

1 reference

7 January 2021

Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice

1 reference

7 January 2021

Auxotrophic vaccines for tuberculosis

1 reference

7 January 2021

Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates

1 reference

7 January 2021

Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model

1 reference

7 January 2021

Identifiers

DOI

10.1038/35095558

1 reference

3 August 2017

1 reference

PubMed ID

11905811